Skip to content

Study · Not a test of the peptide alone · 2014

1 result

[Mechanisms of neurotrophic and neuroprotective effects of cerebrolysin in cerebral ischemia].

Gromova OA, Torshin IIu, Gogoleva IV

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2014Cited by 2 (Europe PMC)

PMID24781241 (opens in a new tab)PepBankPUB-24781241
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 01LabNot a test of Cerebrolysin aloneOther designOther

    Molecular-biological analysis of cerebrolysin identified active fragments of nerve growth factor, enkephalins, orexin and halanin.

    In plain wordsIn lab tests, analysis of cerebrolysin identified active peptide fragments from nerve growth factor, enkephalins, orexin and halanin.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableActive peptide fragment composition
    Study

    n: not reported in source

    Molecular-biological analysis of cerebrolysin peptide content
    Outcome group
    Product quality and purity · Pharmacology

    Source sentences

    Summary
    We have demonstrated the presence of active peptide fragments of nerve growth factor, enkephalins, orexin, halanin.
    1 context sentence
    Summary · context
    In this paper, we present results of a molecular-biological analysis of peptide content of cerebrolysin.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.